Innovating Business Models for the Next Generation
First written in FY2022. 6 of 9 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2023: 2 of 11 companies on the "Worse" side.
7 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「Medium-Term Management Plan 2027 – Move on to the Next Stage – (FY2025–FY2027) / [Medium-Term Vision] "Innovating the business model with the next generation in mind – Phase 2 –"」
As Phase 2 of Medium-Term Management Plan 2027, the Group continues to innovate its business model. - FY2026-H1AdvancedAnnual report
「Against this backdrop, in April 2025 the Company launched the "Medium-Term Management Plan 2027 – Move on to the Next Stage –" (FY2025–FY2027). As a company listed on the TSE Prime Market, it is incorporating into its group management a full-fledged focus on the cost of capital, and is working to strengthen the profitability of existing businesses, review the businesses themselves, and make proactive growth investments, with the aim of achieving sustainable growth for the Group and enhancing corporate value over the medium to long term.」
Medium-Term Management Plan 2027, updated from the Fifth Medium-Term Management Plan, began in April 2025, and the Group has moved into the phase of pursuing management that takes into account the cost of capital, reviewing existing businesses, and making growth investments. - FY2025ReframedAnnual report
「Medium-Term Management Plan 2027 – Move on to the Next Stage – (FY2025–FY2027) / [Medium-Term Vision] "Innovating the business model with the next generation in mind – Phase 2 –"」
The plan has been updated from "Innovating the business model with the next generation in mind" under the Fifth Medium-Term Management Plan to "Phase 2" covering the fiscal years ending March 2026 through March 2028. - FY2025-H1RestatedAnnual report
「Against this backdrop, in the current fiscal year, the final year of the Fifth Medium-Term Management Plan, the Group aims to complete its various initiatives and achieve its earnings plan,」
As the final year of the Fifth Medium-Term Management Plan, the Group is reaffirming its aim of completing its initiatives and achieving its earnings plan. - FY2024-Q3RestatedAnnual report
「The Group is also pursuing the Fifth Medium-Term Management Plan, covering the 3-year period from the fiscal year ended March 2023 through the fiscal year ended March 2025, with "Innovating the business model with the next generation in mind" as its medium-term vision. The Plan sets the following initiatives: "1. Pursuing a pharmaceutical distribution model aligned with structural changes in the market and market characteristics," "2. Evolving the distribution and marketing model in line with advances in healthcare DX," and "3. Promoting group management aligned with the Prime Market," and the Group is working to achieve them.」
The Group is reaffirming the period of the Fifth Medium-Term Management Plan, its medium-term vision, and its 3 initiatives. - FY2024-Q2RestatedAnnual report
「The Group is also pursuing the Fifth Medium-Term Management Plan, covering the 3-year period from the fiscal year ended March 2023 through the fiscal year ended March 2025, with "Innovating the business model with the next generation in mind" as its medium-term vision.」
The Group is reaffirming the period of the Fifth Medium-Term Management Plan and its medium-term vision of "Innovating the business model with the next generation in mind." - FY2024-Q1RestatedAnnual report
「The Group is also pursuing the Fifth Medium-Term Management Plan, covering the 3-year period from the fiscal year ended March 2023 through the fiscal year ended March 2025, with "Innovating the business model with the next generation in mind" as its medium-term vision. The Plan sets the following initiatives: "1. Pursuing a pharmaceutical distribution model aligned with structural changes in the market and market characteristics," "2. Evolving the distribution and marketing model in line with advances in healthcare DX," and "3. Promoting group management aligned with the Prime Market,"」
The Group is reaffirming the period of the Fifth Medium-Term Management Plan, its medium-term vision of "Innovating the business model with the next generation in mind," and its 3 initiatives. - FY2023-Q1RestatedAnnual report
「Under the Fifth Medium-Term Management Plan, the Group will continue pursuing its long-term vision for 2025, namely, "To become an indispensable presence in the healthcare of local communities by strategically providing products and services that support medical care and nursing care," while adopting "Innovating the business model with the next generation in mind" as its medium-term vision,」
Even after the launch of the Fifth Medium-Term Management Plan, the Group continues to pursue both its long-term vision for 2025 and "Innovating the business model with the next generation in mind." - FY2022First statedAnnual report
「The Group formulated its Fifth Medium-Term Management Plan covering the 3-year period from the fiscal year ended March 2023 through the fiscal year ended March 2025. Under the Fifth Medium-Term Management Plan, it will pursue "Innovating the business model with the next generation in mind" as its medium-term vision.」
The new medium-term vision under the Fifth Medium-Term Management Plan covering the fiscal years ended March 2023 through March 2025.